Estimation of the efficacy of endometrial ablation with the thermal balloon technology (ThermaChoice) in the treatment of dysfunctional uterine bleeding – DUB
Journal Title: Ginekologia i Położnictwo medical project - Year 2016, Vol 1, Issue 39
Abstract
ntroduction. Abnormal uterine bleeding has a significant, negative impact on a woman’s everyday activity, and for many women often is a cause of poor health as well as deterioration of the quality of life. Endometrial ablation (EA) is one of the options of conservative treatment of abnormal bleeding from the uterine cavity in those women who wish to retain the uterus and in whom fertility is no longer desired. Material and method. The analysis covered the results of treatments in patients aged from 35 to 57, following ablation due to abnormal functional bleeding from the reproductive tract, with an endometrial destruction technique utilising thermal ablation with the ThermaChoice intrauterine thermal balloon from Johnson & Johnson. Results. Selected patients were interviewed by telephone after the thermal ablation treatment. In 47% of the patients the method used resulted in complete cessation of bleeding by the survey date. In 42% periods returned to normal. In 8% of the patients abnormal bleeding recrudesced (those were patients with myomas who did not consent to uterus removal – owing to thermal ablation the necessity of hysterectomy was able to be delayed). During 15 months after the treatment, 97% of the patients were satisfied with the treatment results, permanent satisfaction was reported by 89% of the patients, and only one patient was not satisfied with the results. Conclusions. The tests demonstrated very high efficacy of the ThermaChoice system in conservative treatment of abnormal uterine bleeding in selected patients. Within the patient population tested no complications were observed, neither immediate nor delayed. Patients treated with the ThermaChoice system report a high level of satisfaction with the results of the procedure performed.
Authors and Affiliations
Jarosław Karoń, Marta Kochanowicz, Ben Rhaiem Tahar
Depresja i lęk w okresie ciąży jako czynnik ryzyka wcześniactwa oraz niskiej masy urodzeniowej – przegląd badań
Mimo iż temat depresji poporodowej jest dobrze zbadany i opisany w dostępnej literaturze medycznej, znacznie mniej wiadomo na temat depresji w okresie ciąży. Tymczasem badania pokazują, że ok. 12 procent kobiet doświadcz...
Czy menopauza i śródmaciczna selekcja zarodków to zjawiska sprzyjające ewolucji i rozwojowi człowieka jako gatunku?
W licznych badaniach medycznych dowiedziono, że kobiety decydujące się na ciąże w starszym wieku znacznie częściej rodzą dzieci z wadami rozwojowymi o różnej etiologii niż młode matki. Przyczyny tego zjawiska nie są jedn...
Comparison of tests using placental alpha-microglobulin 1 (PAMG-1) and type 1 insulin-like growth factor binding protein (IGFBP-1) in the diagnosis of premature rupture of membranes
A diagnosis of premature rupture of membranes (PROM) is mainly based on the interview and physical examination. In a doubtful situation, various tests of cervico-vaginal secretions and ultrasound are used. At present, th...
Noncancerous vulvar disorders – own experience
Vulvar intraepithelial neoplasia (VIN) is one of the rarest vulvar pathologies and its diagnosis is a challenge for gynecologists. Since lesions of the VIN type are believed to be precursor lesions of vulvar squamous cel...
Sprawozdanie z VII Warszawskiego Seminarium Neurourologii – „Czy w Polsce stać nas na leczenie pęcherza neurogennego?”
VII Warszawskie Seminarium Neurourologii odbyło się 28 listopada 2015 roku pod tytułem „Czy w Polsce stać nas na leczenie pęcherza neurogennego?”. Problem pęcherza neurogennego dotyczy około 50 000 pacjentów w Polsce. Są...